e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
Hot topics in molecular pathology and functional genomics of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Introduction “Current perspectives of molecular pathology and functional genomics in neoplastic lung disease”
P.A. Schnabel (Heidelberg, Germany)
Source:
Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer
Session:
Hot topics in molecular pathology and functional genomics of lung cancer
Session type:
Oral Presentation
Number:
3252
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P.A. Schnabel (Heidelberg, Germany). Introduction “Current perspectives of molecular pathology and functional genomics in neoplastic lung disease”. Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
COPD – will new insights into molecular pathology define new therapies?
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014
New findings in the molecular biology of lung cancer: clinical application
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
Omics in population studies: a molecular epidemiology perspective in chronic airway disease
Source: International Congress 2014 – Personalised exposure and gene environment interactions in chronic airway disease: the exposome and epigenome
Year: 2014
Multidisciplinary evaluation of interstitial lung diseases: current insights
Source: Eur Respir Rev, 26 (144) 170002; 10.1183/16000617.0002-2017
Year: 2017
Perspectives of therapeutic innovation from current progress in the pathobiology of pulmonary hypertension
Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Year: 2020
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
Source: Eur Respir J, 53 (1) 1801887; 10.1183/13993003.01887-2018
Year: 2019
Pathogenesis of lung cancer signalling pathways: roadmap for therapies
Source: Eur Respir J 2009; 33: 1485-1497
Year: 2009
Pathology and molecular biology of lung cancer
Source: Annual Congress 2006 - PG19 - Thoracic oncology: diagnostic assessment of lung cancer
Year: 2006
Early origins of lung disease: towards an interdisciplinary approach
Source: Eur Respir Rev, 29 (157) 200191; 10.1183/16000617.0191-2020
Year: 2020
Current and new challenges in occupational lung diseases
Source: Eur Respir Rev, 26 (146) 170080; 10.1183/16000617.0080-2017
Year: 2017
Current and emerging approaches to the genetic diagnosis of chILDs
Source: International Congress 2014 – Interstitial lung disease (ILD) in children
Year: 2014
How to build a lung: latest advances and emerging themes in lung bioengineering
Source: Eur Respir J, 52 (1) 1601355; 10.1183/13993003.01355-2016
Year: 2018
Interstitial lung disease: new challenges and evolving phenotypes
Source: Eur Respir Rev 2009; 19: 91-93
Year: 2010
An introduction to mitochondria in lung biology and disease
Source: International Congress 2018 – Mitochondrial dysfunction as a driver of lung disease
Year: 2018
PET/CT in nononcological lung diseases: current applications and future perspectives
Source: Eur Respir Rev 2016; 25: 247-258
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept